209 related articles for article (PubMed ID: 37338595)
1. Expression variations of DNA damage response genes ATM and ATR in blood cancer patients.
Parvez A; Mahjabeen I; Mehmood A; Khan AU; Nisar A; Kayani MA
Mol Genet Genomics; 2023 Sep; 298(5):1173-1183. PubMed ID: 37338595
[TBL] [Abstract][Full Text] [Related]
2. Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.
Cui Y; Palii SS; Innes CL; Paules RS
Cell Cycle; 2014; 13(22):3541-50. PubMed ID: 25483091
[TBL] [Abstract][Full Text] [Related]
3. Investigation of switch from ATM to ATR signaling at the sites of DNA damage induced by low and high LET radiation.
Saha J; Wang M; Cucinotta FA
DNA Repair (Amst); 2013 Dec; 12(12):1143-51. PubMed ID: 24238855
[TBL] [Abstract][Full Text] [Related]
4. The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response.
Brestovitsky A; Nebenzahl-Sharon K; Kechker P; Sharf R; Kleinberger T
PLoS Pathog; 2016 Feb; 12(2):e1005420. PubMed ID: 26867009
[TBL] [Abstract][Full Text] [Related]
5. DNA-PKcs, ATM, and ATR Interplay Maintains Genome Integrity during Neurogenesis.
Enriquez-Rios V; Dumitrache LC; Downing SM; Li Y; Brown EJ; Russell HR; McKinnon PJ
J Neurosci; 2017 Jan; 37(4):893-905. PubMed ID: 28123024
[TBL] [Abstract][Full Text] [Related]
6. The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma.
Shi Q; Shen LY; Dong B; Fu H; Kang XZ; Yang YB; Dai L; Yan WP; Xiong HC; Liang Z; Chen KN
Cancer Lett; 2018 Sep; 432():56-68. PubMed ID: 29890208
[TBL] [Abstract][Full Text] [Related]
7. HUS1 regulates in vivo responses to genotoxic chemotherapies.
Balmus G; Lim PX; Oswald A; Hume KR; Cassano A; Pierre J; Hill A; Huang W; August A; Stokol T; Southard T; Weiss RS
Oncogene; 2016 Feb; 35(5):662-9. PubMed ID: 25915840
[TBL] [Abstract][Full Text] [Related]
8. DNA damage response and hematological malignancy.
Takagi M
Int J Hematol; 2017 Sep; 106(3):345-356. PubMed ID: 28374143
[TBL] [Abstract][Full Text] [Related]
9. Targeting ATM and ATR for cancer therapeutics: Inhibitors in clinic.
Priya B; Ravi S; Kirubakaran S
Drug Discov Today; 2023 Aug; 28(8):103662. PubMed ID: 37302542
[TBL] [Abstract][Full Text] [Related]
10. 2-Mercaptoethanol protects against DNA double-strand breaks after kidney ischemia and reperfusion injury through GPX4 upregulation.
Moon D; Padanilam BJ; Jang HS; Kim J
Pharmacol Rep; 2022 Oct; 74(5):1041-1053. PubMed ID: 35989399
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targeting of a robust non-oncogene addiction to PRKDC in ATM-defective tumors.
Riabinska A; Daheim M; Herter-Sprie GS; Winkler J; Fritz C; Hallek M; Thomas RK; Kreuzer KA; Frenzel LP; Monfared P; Martins-Boucas J; Chen S; Reinhardt HC
Sci Transl Med; 2013 Jun; 5(189):189ra78. PubMed ID: 23761041
[TBL] [Abstract][Full Text] [Related]
12. ATM, ATR and DNA-PKcs kinases-the lessons from the mouse models: inhibition ≠ deletion.
Menolfi D; Zha S
Cell Biosci; 2020; 10():8. PubMed ID: 32015826
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen peroxide and Helicobacter pylori extract treatment combined with APE1 knockdown induce DNA damage, G2/M arrest and cell death in gastric cancer cell line.
Manoel-Caetano FS; Rossi AFT; Ribeiro ML; Prates J; Oliani SM; Silva AE
DNA Repair (Amst); 2020 Dec; 96():102976. PubMed ID: 33065487
[TBL] [Abstract][Full Text] [Related]
14. Roles of ATM and ATR-mediated DNA damage responses during lytic BK polyomavirus infection.
Jiang M; Zhao L; Gamez M; Imperiale MJ
PLoS Pathog; 2012; 8(8):e1002898. PubMed ID: 22952448
[TBL] [Abstract][Full Text] [Related]
15. ATM and ATR as therapeutic targets in cancer.
Weber AM; Ryan AJ
Pharmacol Ther; 2015 May; 149():124-38. PubMed ID: 25512053
[TBL] [Abstract][Full Text] [Related]
16. The complexity of DNA double strand break is a crucial factor for activating ATR signaling pathway for G2/M checkpoint regulation regardless of ATM function.
Xue L; Furusawa Y; Okayasu R; Miura M; Cui X; Liu C; Hirayama R; Matsumoto Y; Yajima H; Yu D
DNA Repair (Amst); 2015 Jan; 25():72-83. PubMed ID: 25497328
[TBL] [Abstract][Full Text] [Related]
17. Targeting ATR Pathway in Solid Tumors: Evidence of Improving Therapeutic Outcomes.
Mavroeidi D; Georganta A; Panagiotou E; Syrigos K; Souliotis VL
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474014
[TBL] [Abstract][Full Text] [Related]
18. Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.
Eich M; Roos WP; Nikolova T; Kaina B
Mol Cancer Ther; 2013 Nov; 12(11):2529-40. PubMed ID: 23960094
[TBL] [Abstract][Full Text] [Related]
19. Viral DNA replication-dependent DNA damage response activation during BK polyomavirus infection.
Verhalen B; Justice JL; Imperiale MJ; Jiang M
J Virol; 2015 May; 89(9):5032-9. PubMed ID: 25694603
[TBL] [Abstract][Full Text] [Related]
20. DNA damage sensing by the ATM and ATR kinases.
Maréchal A; Zou L
Cold Spring Harb Perspect Biol; 2013 Sep; 5(9):. PubMed ID: 24003211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]